New Owner to Sustain Lek's Development, Says Novartis Generics CEO

Basel, 21 November - Novartis is very pleased with the result of its takeover bid on Slovenian pharma stock Lek, wrote Novartis Generics' executive director Christian Seiwald in a press release on Thursday. The bid was successful, according to the Slovenian Securities Agency, as over 99 percent of Lek stockholders accepted the offer.

The rest of this news item is available to subscribers.
The news item consists of 855 characters (without spaces) or 155 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

© STA, 2002